Linked Data API

Show Search Form

Search Results

1203560
star this property registered interest false more like this
star this property date less than 2020-06-15more like thismore than 2020-06-15
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Drugs remove filter
star this property house id 2 more like this
star this property legislature
25277
unstar this property pref label House of Lords more like this
star this property question text Her Majesty's Government what assessment they have made about whether any drugs or medicines will be in short supply after the UK leaves the EU. more like this
star this property tabling member printed
Lord Roberts of Llandudno more like this
star this property uin HL5715 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2020-06-30more like thismore than 2020-06-30
star this property answer text <p>The United Kingdom left the European Union on 31 January and is now in a Transition Period until 31 December 2020. During this time, it remains our objective to negotiate a future relationship with the EU and in our respective published negotiating documents, we have both stated objectives to reach an agreement on trade in goods. The UK’s published approach sets out how we want to facilitate trade in medicinal products and support high levels of patient safety.</p><p>The Government, pharmaceutical industry and National Health Service will always work closely together to help ensure patients continue to have access, to the medicines and treatments they need, including insulin, under all scenarios.</p><p>The Department has well-established procedures to deal with medicine shortages and is working closely with industry, the NHS and others in the supply chain to reduce the likelihood of future shortages resulting from any cause.</p><p> </p> more like this
star this property answering member printed Lord Bethell more like this
star this property grouped question UIN HL5713 more like this
star this property question first answered
remove maximum value filtermore like thismore than 2020-06-30T15:47:39.5Z
star this property answering member
4708
star this property label Biography information for Lord Bethell more like this
star this property tabling member
3691
star this property label Biography information for Lord Roberts of Llandudno more like this
1186624
star this property registered interest false more like this
star this property date less than 2020-03-19more like thismore than 2020-03-19
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans he has to manufacture more active pharmaceutical ingredients in the UK to prevent medicine shortages. more like this
star this property tabling member constituency Coventry North West more like this
star this property tabling member printed
Taiwo Owatemi more like this
star this property uin 32261 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2020-04-14more like thismore than 2020-04-14
star this property answer text <p>The Government has no plans to create facilities in the United Kingdom to manufacture further active pharmaceutical ingredients. There are 16,000 medicines on the market in the UK. Whilst some of these are manufactured in the UK, most are manufactured abroad. Where medicines are manufactured here, the active ingredients and excipients for those medicines may be manufactured abroad. It is not realistic to manufacture all 16,000 medicines and the active ingredients and excipients needed for these medicines in the UK.</p><p>The production of medicines is complex and highly regulated, and materials and processes must meet rigorous safety and quality standards. Supply problems can affect a wide range of medicines and can arise for various reasons, such as manufacturing issues, problems with the raw ingredients and batch failures. These problems arise regardless of where in the world the manufacture takes place.</p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2020-04-14T14:50:24.04Zmore like thisremove minimum value filter
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property previous answer version
14443
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4779
star this property label Biography information for Taiwo Owatemi more like this